Cite
HARVARD Citation
Geschwind, K. et al. (2022). Is a serotonin–norepinephrine reuptake inhibitor superior to an SSRI in the treatment of major depressive disorder in adults?. Evidence-based practice. 25 (1), pp. 36-37. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Geschwind, K. et al. (2022). Is a serotonin–norepinephrine reuptake inhibitor superior to an SSRI in the treatment of major depressive disorder in adults?. Evidence-based practice. 25 (1), pp. 36-37. [Online].